NO994304L - Fremgangsmåte for fremstilling av 2-tienyletylamin-derivater - Google Patents

Fremgangsmåte for fremstilling av 2-tienyletylamin-derivater

Info

Publication number
NO994304L
NO994304L NO994304A NO994304A NO994304L NO 994304 L NO994304 L NO 994304L NO 994304 A NO994304 A NO 994304A NO 994304 A NO994304 A NO 994304A NO 994304 L NO994304 L NO 994304L
Authority
NO
Norway
Prior art keywords
pct
general formula
alkali metal
metal atom
date sep
Prior art date
Application number
NO994304A
Other languages
English (en)
Other versions
NO323613B1 (no
NO994304D0 (no
Inventor
Bertrand Castro
Jean-Robert Dormoy
Aldo Previero
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO994304D0 publication Critical patent/NO994304D0/no
Publication of NO994304L publication Critical patent/NO994304L/no
Publication of NO323613B1 publication Critical patent/NO323613B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO19994304A 1997-03-05 1999-09-03 Fremgangsmate for fremstilling av 2-tienyletylamin-derivater NO323613B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702621A FR2760456B1 (fr) 1997-03-05 1997-03-05 Procede de preparation de derives de 2-thienyl-ethylamine
PCT/FR1998/000441 WO1998039322A1 (fr) 1997-03-05 1998-03-05 Procede de preparation de derives de 2-thienylethylamine

Publications (3)

Publication Number Publication Date
NO994304D0 NO994304D0 (no) 1999-09-03
NO994304L true NO994304L (no) 1999-11-03
NO323613B1 NO323613B1 (no) 2007-06-18

Family

ID=9504438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994304A NO323613B1 (no) 1997-03-05 1999-09-03 Fremgangsmate for fremstilling av 2-tienyletylamin-derivater

Country Status (12)

Country Link
US (1) US6080875A (no)
EP (1) EP0971915B1 (no)
JP (1) JP4283896B2 (no)
AT (1) ATE240311T1 (no)
AU (1) AU6839498A (no)
BR (1) BR9808174B1 (no)
CA (1) CA2283126C (no)
DE (1) DE69814608T2 (no)
ES (1) ES2200332T3 (no)
FR (1) FR2760456B1 (no)
NO (1) NO323613B1 (no)
WO (1) WO1998039322A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
US8907090B2 (en) 2003-11-03 2014-12-09 Cadila Healthcare Limited Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate
WO2006003671A1 (en) * 2004-07-02 2006-01-12 Srinivasa Reddy Battula A process for resolution of methylamino(2-chlorophenyl)acetate
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
EP1851231A2 (en) * 2005-02-24 2007-11-07 Teva Pharmaceutical Industries Ltd Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
EP1931682A2 (en) * 2006-08-03 2008-06-18 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
KR20090086903A (ko) * 2007-04-18 2009-08-14 테바 파마슈티컬 인더스트리즈 리미티드 개선된 클로피도그렐의 제조 방법
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) * 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
WO2010046476A1 (en) * 2008-10-24 2010-04-29 Sandoz Ag A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN103172527A (zh) * 2011-12-26 2013-06-26 湖北德洲科技发展有限公司 一种制备氯吡格雷合成中间体-邻氯苯甘氨酸甲酯的方法
SI2874625T1 (sl) * 2012-07-17 2017-10-30 Sanofi Uporaba inhibitorjev VEGFR-3 za zdravljenje hepatoceličnega karcinoma
CN106748853B (zh) * 2016-11-25 2018-12-28 河南普瑞医药科技有限公司 一种（s）-邻氯苯甘氨酸甲酯盐酸盐的制备方法
CN115784914B (zh) * 2022-12-20 2023-05-12 石家庄中硕科技有限公司 一种邻氯苯甘氨酸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355170A4 (en) * 1986-04-24 1990-09-05 N-Proizv Mekh Robot Truda Sover Vertical centrifugal casting machine
FR2624860B1 (fr) * 1987-12-18 1990-06-01 Sanofi Sa Procede de preparation de la n-(chloro-2 benzyl) (thienyl-2)-2 ethylamine
AR245119A1 (es) * 1988-08-22 1993-12-30 Merrell Dow Pharma Procedimiento para preparar un grupo de fenilalquiltiofenos que estan sustituidos adicionalmente con un grupo acido tiadicarboxilico.
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
WO1998039322A1 (fr) 1998-09-11
ES2200332T3 (es) 2004-03-01
EP0971915A1 (fr) 2000-01-19
JP4283896B2 (ja) 2009-06-24
US6080875A (en) 2000-06-27
CA2283126C (fr) 2008-09-02
AU6839498A (en) 1998-09-22
BR9808174A (pt) 2000-05-16
FR2760456A1 (fr) 1998-09-11
JP2001513806A (ja) 2001-09-04
NO323613B1 (no) 2007-06-18
CA2283126A1 (fr) 1998-09-11
DE69814608T2 (de) 2004-04-01
DE69814608D1 (de) 2003-06-18
FR2760456B1 (fr) 2000-05-12
NO994304D0 (no) 1999-09-03
EP0971915B1 (fr) 2003-05-14
BR9808174B1 (pt) 2010-06-29
ATE240311T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
NO994304L (no) Fremgangsmåte for fremstilling av 2-tienyletylamin-derivater
PL317726A1 (en) Novel compounds, methods of obtaining them and antineoplastic agents
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
ATE187445T1 (de) Verfahren zur herstellung von chinazolinderivaten
EA200500268A1 (ru) Производные диоксан-2-алкилкарбаматов, способ их получения и применение в терапии
ES466531A1 (es) Procedimiento para preparar haloacetanilidas n-sustituidas
EP0342665A3 (en) Physiologically active substance tan-931, its derivatives, their production and use
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
IL131177A (en) Process for the preparation of nicotinic acids and esters
DE69604642D1 (de) Verfahren zur herstellung von iodierten kontrastmitteln
DK412587A (da) Quinolinderivater og disses fremstilling
ATE249459T1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
NO873097L (no) Fremstilling av 1-methylaminokinolincarboxylsyrederivater.
ATE236132T1 (de) Verfahren zur herstellung von 1,3-diaza- spiro(4.4)non-1-en-4-on derivaten und 1-cyano-1- acylaminocyclopentan zwischenprodukte
ATE226942T1 (de) Verfahren zur herstellung von 1,3-diaza- spiro(4.4)non-1-en-4-on derivaten und 1-cyano-1- acylamino-cyclopentan zwischenprodukten
HUP0002772A2 (hu) Eljárás királis 3,4-dehidroprolinok előállítására
JPS6416746A (en) Anisole derivative and production thereof
DE60004747D1 (de) Verfahren zur Herstellung von 3-(3-Pyridyl)-1-Propanol Derivaten

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees